Impact of G-CSF on Donor TCR Clonal Diversity and T Cell Function During Donor HSC Mobilisation

Xinye Li1,2, Zhixi Chen1,2, Jie Chen2

  • 1State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Basic Research Center of Excellence for Natural Bioactive Molecules and Discovery of Innovative Drugs, Key Laboratory for Regenerative Medicine, Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China.

Cell Proliferation
|April 16, 2026
PubMed

Recombinant granulocyte colony-stimulating factor (G-CSF) is widely used to mobilise donor stem cells into peripheral blood for allogeneic haematopoietic stem cell transplantation (allo-HSCT). Studies have shown that G-CSF may reduce the incidence of acute graft-versus-host disease (aGVHD) following allo-HSCT by modulating T cell function. However, the patterns and mechanisms by which G-CSF regulates T cell function remain unclear. In this study, we used RNA sequencing combined with T cell receptor (TCR) immune repertoire sequencing to discover that G-CSF mobilisation leads to a reduction in donor TCR clonal diversity, downregulation of genes associated with TCR recombination, suppression of multiple antigen presentation processes, and varying degrees of downregulation in multiple T cell function-related signalling pathways. The results suggest that the pathway by which G-CSF mediates a low incidence of GVHD after allo-HSCT is by interfering with donor TCR recombination and antigen presentation processes, resulting in suppression of multiple T cell functions.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.9K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
88.4K